7th Edition of Global Conference on
Addiction Medicine, Behavioral Health and Psychiatry
October 19-21, 2026 | Boston, Massachusetts, USA
Substance Use Harm Reduction Strategies
Harm reduction refers to policies and practices designed to minimize the negative health and social impacts of substance use without necessarily requiring abstinence. These strategies include needle exchange programs, supervised injection sites, and the distribution of naloxone (a medication that reverses opioid overdoses). Harm reduction also emphasizes providing education about safer drug use, offering mental health support, and facilitating access to treatment services. Rather than focusing solely on stopping substance use, harm reduction seeks to improve overall quality of life for individuals while they navigate the recovery process. Evidence suggests that harm reduction can be a highly effective approach, particularly for those who are not ready or able to quit substances immediately.
Frederick J Goldstein
Philadelphia College of Osteopathic Medicine, United States
Nile Stanley
University of North Florida, United States
Ann Marie Leonard Zabel
Curry College, United States
John Michael Weber
Trauma Healed Life Coach, United States
Denis Larrivee
University of Navarra, Spain
Steve Cohen
Medvesta Hypnosis Healthcare, United States
Andrew Drasen
A Vision of Hope Media, United StatesSubmit your abstract Today
Title : The storm within: Neuropsychological insights into dysregulation and substance use in the adolescent brain
Ann Marie Leonard Zabel, Curry College, United States
Title : Integrating bibliopoetry therapy and digital health technologies for inflammation management: A neuropsychosomatic perspective
Nile Stanley, University of North Florida, United States
Title : Trauma: Till death do us part
John Michael Weber, Trauma Healed Life Coach, United States
Title : Addiction and the failure of meaning-forming
Jenni Guentcheva, GTI, United States
Title : Beating the blues today
Steve Cohen, Medvesta Hypnosis Healthcare, United States
Title : Reduction of chronic neuropathic pain by a THC-CBD combination capsule: ongoing pilot study
Frederick J Goldstein, Philadelphia College of Osteopathic Medicine, United States